STAT5 induces miR-21 expression in cutaneous T cell lymphoma

In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21. Here, we demonstrate miR-21 expression in sit...

Full description

Bibliographic Details
Main Authors: Lindahl, Lise M., Fredholm, Simon, Joseph, Claudine, Nielsen, Boye Schnack, Jønson, Lars, Willerslev-Olsen, Andreas, Gluud, Maria, Blümel, Edda, Petersen, David L., Sibbesen, Nina, Hu, Tengpeng, Nastasi, Claudia, Krejsgaard, Thorbjørn, Jæhger, Ditte, Persson, Jenny L., Mongan, Nigel P., Wasik, Mariusz A., Litvinov, Ivan V., Sasseville, Denis, Koralov, Sergei B., Bonefeld, Charlotte M., Geisler, Carsten, Woetmann, Anders, Ralfkiaer, Elisabeth, Iversen, Lars, Odum, Niels
Format: Article
Published: Impact 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/36661/
_version_ 1848795325124313088
author Lindahl, Lise M.
Fredholm, Simon
Joseph, Claudine
Nielsen, Boye Schnack
Jønson, Lars
Willerslev-Olsen, Andreas
Gluud, Maria
Blümel, Edda
Petersen, David L.
Sibbesen, Nina
Hu, Tengpeng
Nastasi, Claudia
Krejsgaard, Thorbjørn
Jæhger, Ditte
Persson, Jenny L.
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Sasseville, Denis
Koralov, Sergei B.
Bonefeld, Charlotte M.
Geisler, Carsten
Woetmann, Anders
Ralfkiaer, Elisabeth
Iversen, Lars
Odum, Niels
author_facet Lindahl, Lise M.
Fredholm, Simon
Joseph, Claudine
Nielsen, Boye Schnack
Jønson, Lars
Willerslev-Olsen, Andreas
Gluud, Maria
Blümel, Edda
Petersen, David L.
Sibbesen, Nina
Hu, Tengpeng
Nastasi, Claudia
Krejsgaard, Thorbjørn
Jæhger, Ditte
Persson, Jenny L.
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Sasseville, Denis
Koralov, Sergei B.
Bonefeld, Charlotte M.
Geisler, Carsten
Woetmann, Anders
Ralfkiaer, Elisabeth
Iversen, Lars
Odum, Niels
author_sort Lindahl, Lise M.
building Nottingham Research Data Repository
collection Online Access
description In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21. Here, we demonstrate miR-21 expression in situ in both malignant and reactive lymphocytes as well as stromal cells. qRT-PCR analysis of 47 patients with mycosis fungoides (MF) and Sezary Syndrome (SS) confirmed an increased miR-21 expression that correlated with progressive disease. In cultured malignant T cells miR-21 expression was inhibited by Tofacitinib (CP-690550), a clinical-grade JAK3 inhibitor. Chromatin immunoprecipitation (ChIP) analysis showed direct binding of STAT5 to the miR-21 promoter. Cytokine starvation ex vivo triggered a decrease in miR-21 expression, whereas IL-2 induced an increased miR-21 expression in primary SS T cells and cultured cytokine-dependent SS cells (SeAx). siRNA-mediated depletion of STAT5 inhibited constitutive- and IL-2-induced miR-21 expression in cytokine-independent and dependent T cell lines, respectively. IL-15 and IL-2 were more potent than IL-21 in inducing miR-21 expression in the cytokine-dependent T cells. In conclusion, we provide first evidence that miR-21 is expressed in situ in CTCL skin lesions, induced by IL-2 and IL-15 cytokines, and is regulated by STAT5 in malignant T cells. Thus, our data provide novel evidence for a pathological role of IL-2Rg cytokines in promoting expression of the oncogenic miR-21 in CTCL.
first_indexed 2025-11-14T19:30:17Z
format Article
id nottingham-36661
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:30:17Z
publishDate 2016
publisher Impact
recordtype eprints
repository_type Digital Repository
spelling nottingham-366612020-05-04T17:55:58Z https://eprints.nottingham.ac.uk/36661/ STAT5 induces miR-21 expression in cutaneous T cell lymphoma Lindahl, Lise M. Fredholm, Simon Joseph, Claudine Nielsen, Boye Schnack Jønson, Lars Willerslev-Olsen, Andreas Gluud, Maria Blümel, Edda Petersen, David L. Sibbesen, Nina Hu, Tengpeng Nastasi, Claudia Krejsgaard, Thorbjørn Jæhger, Ditte Persson, Jenny L. Mongan, Nigel P. Wasik, Mariusz A. Litvinov, Ivan V. Sasseville, Denis Koralov, Sergei B. Bonefeld, Charlotte M. Geisler, Carsten Woetmann, Anders Ralfkiaer, Elisabeth Iversen, Lars Odum, Niels In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21. Here, we demonstrate miR-21 expression in situ in both malignant and reactive lymphocytes as well as stromal cells. qRT-PCR analysis of 47 patients with mycosis fungoides (MF) and Sezary Syndrome (SS) confirmed an increased miR-21 expression that correlated with progressive disease. In cultured malignant T cells miR-21 expression was inhibited by Tofacitinib (CP-690550), a clinical-grade JAK3 inhibitor. Chromatin immunoprecipitation (ChIP) analysis showed direct binding of STAT5 to the miR-21 promoter. Cytokine starvation ex vivo triggered a decrease in miR-21 expression, whereas IL-2 induced an increased miR-21 expression in primary SS T cells and cultured cytokine-dependent SS cells (SeAx). siRNA-mediated depletion of STAT5 inhibited constitutive- and IL-2-induced miR-21 expression in cytokine-independent and dependent T cell lines, respectively. IL-15 and IL-2 were more potent than IL-21 in inducing miR-21 expression in the cytokine-dependent T cells. In conclusion, we provide first evidence that miR-21 is expressed in situ in CTCL skin lesions, induced by IL-2 and IL-15 cytokines, and is regulated by STAT5 in malignant T cells. Thus, our data provide novel evidence for a pathological role of IL-2Rg cytokines in promoting expression of the oncogenic miR-21 in CTCL. Impact 2016-06-18 Article PeerReviewed Lindahl, Lise M., Fredholm, Simon, Joseph, Claudine, Nielsen, Boye Schnack, Jønson, Lars, Willerslev-Olsen, Andreas, Gluud, Maria, Blümel, Edda, Petersen, David L., Sibbesen, Nina, Hu, Tengpeng, Nastasi, Claudia, Krejsgaard, Thorbjørn, Jæhger, Ditte, Persson, Jenny L., Mongan, Nigel P., Wasik, Mariusz A., Litvinov, Ivan V., Sasseville, Denis, Koralov, Sergei B., Bonefeld, Charlotte M., Geisler, Carsten, Woetmann, Anders, Ralfkiaer, Elisabeth, Iversen, Lars and Odum, Niels (2016) STAT5 induces miR-21 expression in cutaneous T cell lymphoma. Oncotarget . ISSN 1949-2553 MiR-21 in situ STAT5 IL-2 Cutaneous T-cell lymphoma (CTCL) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=10160 doi:10.18632/oncotarget.10160 doi:10.18632/oncotarget.10160
spellingShingle MiR-21
in situ
STAT5
IL-2
Cutaneous T-cell lymphoma (CTCL)
Lindahl, Lise M.
Fredholm, Simon
Joseph, Claudine
Nielsen, Boye Schnack
Jønson, Lars
Willerslev-Olsen, Andreas
Gluud, Maria
Blümel, Edda
Petersen, David L.
Sibbesen, Nina
Hu, Tengpeng
Nastasi, Claudia
Krejsgaard, Thorbjørn
Jæhger, Ditte
Persson, Jenny L.
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Sasseville, Denis
Koralov, Sergei B.
Bonefeld, Charlotte M.
Geisler, Carsten
Woetmann, Anders
Ralfkiaer, Elisabeth
Iversen, Lars
Odum, Niels
STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title_full STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title_fullStr STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title_full_unstemmed STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title_short STAT5 induces miR-21 expression in cutaneous T cell lymphoma
title_sort stat5 induces mir-21 expression in cutaneous t cell lymphoma
topic MiR-21
in situ
STAT5
IL-2
Cutaneous T-cell lymphoma (CTCL)
url https://eprints.nottingham.ac.uk/36661/
https://eprints.nottingham.ac.uk/36661/
https://eprints.nottingham.ac.uk/36661/